Visit, budget and sponsor-payment tracking for Indian trial sites
TL;DR Studydesk is software for the money side of running clinical trials at an Indian hospital or site management organisation. It links each completed patient visit to the study budget, raises the sponsor invoice and shows who is owed what. Sites pay a monthly fee per active study.
An Indian research site may run a dozen industry studies at once, each with its own budget, visit schedule and payment terms. Most of the 1,385 phase III trials on CTRI were industry-funded (84.7%) and 90.7% were multicentre[1], so a busy site juggles many sponsors. Coordinators track completed visits in spreadsheets, finance teams chase CROs for payment months later, and investigators often can't tell which visits have been paid.
I found no public data on payment delays to Indian sites, which tells you how little anyone measures this. What is clear is that protocol complexity tops investigators' list of problems, cited by 38% in one survey[2].
Regulatory scope: site operations and finance software, not trial data capture. Studydesk holds visit dates, budgets and invoices. It doesn't store case report forms or make clinical decisions, though it still handles participants' identifiers and must follow data-protection law.
A coordinator loads each study's budget and visit schedule once. As visits happen she ticks them off, and Studydesk works out what the sponsor owes, flags out-of-window visits that may not be paid, produces the invoice with GST and shows the investigator, the hospital and the site team their agreed split. A dashboard shows unpaid amounts by sponsor and age.
The seed pitched AI predictive analytics for trial management, and I've reframed it. Prediction needs clean history that small sites don't keep, and a global life-sciences software firm already gives most sites a free management tool[3]. Studydesk starts with bookkeeping and only adds simple forecasts, such as which studies will miss enrolment, after a year of clean data.
The buyer is the site - a private hospital research office, a site management organisation or a high-volume investigator's practice. They pay a monthly fee per active study, which I'd assume is a few thousand rupees until it is tested. The pitch is cash, plain and simple. Invoices raised the day visits happen get paid sooner. CROs may later pay to receive clean invoices automatically.
CRO registration became mandatory on 1 April 2025, and CROs must keep trial records for five years[4], which pushes the whole chain toward tidier paperwork. A trade publication, citing Invest India, reports nearly 18,000 new studies registered in 2024[4]. The DPDP Rules notified on 14 November 2025 put new duties on any software holding participant details[5].
There's no public count of active research sites or SMOs in India. The indirect anchors - CTRI shows 120,027 trials registered to date[6], and phase III registrations rose from 406 in 2007–2014 to 979 in 2015–2025[1].
The adjacent figure is India's clinical trials market at US$2.05 billion in 2024 (about ₹19,800 Cr)[4]. Site software is a small slice of that.
The leading free site platform offers sites a management system, electronic binders and eConsent, free for 90% of sites, with 2,000+ monthly active sites[3]. Indian trial-software vendors sell trial management and data capture, mostly to sponsors and CROs[7][8]. Going by their public pages, none of them focuses on Indian site finance like GST invoices, investigator splits and sponsor payment ageing. That narrow gap is the opening.
| Difficulty | Moderate (36/100) |
| Starting capital | ₹45–85 L |
| Time to launch | 6–9 months |
The software is ordinary. The hard part is selling to research offices that have little budget and a free alternative for the operational side. You have to show money recovered within one quarter, and every sponsor's budget format is different, so onboarding the first studies is manual work.
No special licence. The software doesn't capture trial data or make clinical claims, so you start with the baseline.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI post invoices or GST on its own. Money and tax errors land on the site, so a person approves every invoice before it goes out.
Want to work out the AI layer for Studydesk? Talk to Yash →
Here's what can go south -
I see this as a modest, practical software business for a founder who has worked in site finance or an SMO. It is not a venture-scale story on its own, and that's fine. Prove first that, at three sites, Studydesk cuts the average age of unpaid sponsor invoices by a month in one quarter.
Plan for roughly ₹45–85 L, mostly product build and the manual onboarding of the first studies.
No special licence. You need company registration, GST, DPDP processor terms with each site and an audit trail that supports five-year record duties.
Yes, sites everywhere chase sponsor payments. You'd rebuild the tax rules for your country and check how free site tools compete there.
The free Studydesk validation kit has the line-by-line capital breakdown, the effort scoring, the data-protection and record-keeping checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for sites and SMOs, and 5 assumptions to test. Download the kit →
Thinking about building Studydesk or something close to it? The hard part is getting a cash-strapped research office to pay when a free tool exists, and that's a pricing puzzle I like working on with founders. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.